Novo Nordisk and Novartis will participate in large Danish project on decentralized clinical trials
A consortium of industry players has pooled over DKK 48m (USD 6.2m) to develop a digital platform meant to help recruit patients, collect data, and make it easier to conduct clinical studies – digitally.
by albert rønning-andersson, translated by daniel pedersen
Novo Nordisk, Novartis, and Monsenso. The Innovation Fund Denmark and Danish Life science Cluster. Universities, hospitals, and municipalities.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.